首页> 外文期刊>中国神经再生研究(英文版) >On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system
【24h】

On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system

机译:在多发性硬化症新疗法的道路上:靶向树突状细胞迁移到中枢神经系统

获取原文
获取原文并翻译 | 示例
       

摘要

Distinct migratory pathways and trafficking of dendritic cells to the central nervous system (CNS): The immune system is a host defense mechanism protecting against invaders, such as bacteria and viruses, while maintaining tolerance to self. Nonetheless, a few sites throughout the body are believed to be immunologically inert, such as the testes, the eye and the brain. Indeed, experiments in the mid-20th century gave rise to the concept of the brain as a site of immune privilege. Originally, the immune privilege of the brain was thought to be absolute, attributed by a physical blood-brain barrier (BBB) protecting the CNS from the entry of pathogens and circulating immune cells. These views have changed and currently, the CNS is seen as an immune-specialized site regulated by immunological components into and within the CNS.

著录项

  • 来源
    《中国神经再生研究(英文版)》 |2019年第12期|2088-2090|共3页
  • 作者

    Megha Meena; Nathalie Cools;

  • 作者单位

    Laboratory of Experimental Hematology Vaccine & Infectious Disease Institute (VAXINFECTIO) Faculty of Medicine and Health Sciences University of Antwerp Wilrijk Belgium;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:37:09
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号